These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17588203)

  • 1. FBXW7 and DNA copy number instability.
    Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG
    Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
    Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
    Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
    Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M
    Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCs.
    Yokobori T; Yokoyama Y; Mogi A; Endoh H; Altan B; Kosaka T; Yamaki E; Yajima T; Tomizawa K; Azuma Y; Onozato R; Miyazaki T; Tanaka S; Kuwano H
    Mol Cancer Res; 2014 Jan; 12(1):32-7. PubMed ID: 24165483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner.
    Yumimoto K; Akiyoshi S; Ueo H; Sagara Y; Onoyama I; Ueo H; Ohno S; Mori M; Mimori K; Nakayama KI
    J Clin Invest; 2015 Feb; 125(2):621-35. PubMed ID: 25555218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
    Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
    Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells.
    Willmarth NE; Albertson DG; Ethier SP
    Breast Cancer Res; 2004; 6(5):R531-9. PubMed ID: 15318934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
    Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
    Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
    Xu Y; Sengupta T; Kukreja L; Minella AC
    J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of genomic instability and epithelial tumor development by the p53-Fbxw7/Cdc4 pathway.
    Perez-Losada J; Mao JH; Balmain A
    Cancer Res; 2005 Aug; 65(15):6488-92. PubMed ID: 16061623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
    Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
    Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FBXW7 beta-form is suppressed in human glioma cells.
    Gu Z; Inomata K; Ishizawa K; Horii A
    Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.
    Akhoondi S; Lindström L; Widschwendter M; Corcoran M; Bergh J; Spruck C; Grandér D; Sangfelt O
    Breast Cancer Res; 2010; 12(6):R105. PubMed ID: 21122106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.
    Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I
    Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma.
    Li L; Sarver AL; Khatri R; Hajeri PB; Kamenev I; French AJ; Thibodeau SN; Steer CJ; Subramanian S
    J Pathol; 2014 Dec; 234(4):488-501. PubMed ID: 25269767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
    Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
    Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.
    Yokobori T; Mimori K; Iwatsuki M; Ishii H; Onoyama I; Fukagawa T; Kuwano H; Nakayama KI; Mori M
    Cancer Res; 2009 May; 69(9):3788-94. PubMed ID: 19366810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hCDC4 variation in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Seto KK; Bell RS; Andrulis IL
    Cancer Genet Cytogenet; 2006 Sep; 169(2):138-42. PubMed ID: 16938571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.